Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 8 - Number 5

FHIT and p53 Status and Response to Platinum-Based Treatment in Advanced Non-Small Cell Lung Cancer

, 8(5): 342 - 348

D. L. Cortinovis, F. Andriani, A. Livio, A. Fabbri, F. Perrone, B. Marcomini, S. Pilotti, L. Mariani, P. Bidoli, E. Bajetta, L. Roz and G. Sozzi


DOI: 10.2174/156800908785133204






Targeting Blood Vessels for the Treatment of Non-Small Cell Lung Cancer

, 8(5): 392 - 403

Ethan Amir, Sarah Hughes, Fiona Blackhall, Nick Thatcher, Gyula Ostoros, Jozsef Timar, Jozsef Tovari, Gabor Kovacs and Balazs Dome


DOI: 10.2174/156800908785133187



Celecoxib Upregulates Multidrug Resistance Proteins in Colon Cancer: Lack of Synergy with Standard Chemotherapy

, 8(5): 414 - 420

A. Gradilone, F. M. Pulcinelli, L. V. Lotti, E. Trifiro, S. Martino, O. Gandini, W. Gianni, L. Frati, A. M. Agliano and P. Gazzaniga


DOI: 10.2174/156800908785133178





Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75

Advertisement

New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog